S
Sarah E. Fowler
Researcher at George Washington University
Publications - 39
Citations - 28806
Sarah E. Fowler is an academic researcher from George Washington University. The author has contributed to research in topics: Diabetes mellitus & Metformin. The author has an hindex of 29, co-authored 36 publications receiving 27001 citations. Previous affiliations of Sarah E. Fowler include Henry Ford Hospital.
Papers
More filters
Journal ArticleDOI
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
William C. Knowler,Elizabeth Barrett-Connor,Sarah E. Fowler,Richard F. Hamman,John M. Lachin,Elizabeth A. Walker,David M. Nathan +6 more
TL;DR: In this paper, the authors compared a lifestyle intervention with metformin to prevent or delay the development of Type 2 diabetes in nondiabetic individuals. And they found that the lifestyle intervention was significantly more effective than the medication.
Journal ArticleDOI
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.
William C. Knowler,Sarah E. Fowler,Richard F. Hamman,Costas A. Christophi,Heather J. Hoffman,Anne T Brenneman,J. Brown-Friday,Ronald N. Goldberg,Elizabeth M. Venditti,David M. Nathan +9 more
TL;DR: During follow-up after DPP, incidences in the former placebo and metformin groups fell to equal those in theFormer lifestyle group, but the cumulative incidence of diabetes remained lowest in the lifestyle group.
Journal ArticleDOI
Multidetector Computed Tomography for Acute Pulmonary Embolism
Paul D. Stein,Sarah E. Fowler,Lawrence R. Goodman,Alexander Gottschalk,Charles A. Hales,Russell D. Hull,Kenneth V. Leeper,John Popovich,Deborah A. Quinn,Thomas A. Sos,H. Dirk Sostman,Victor F. Tapson,Thomas W. Wakefield,John G. Weg,Pamela K. Woodard +14 more
TL;DR: In patients with suspected pulmonary embolism, multidetector CTA-CTV has a higher diagnostic sensitivity than does CTA alone, with similar specificity, and additional testing is necessary when the clinical probability is inconsistent with the imaging results.
Journal ArticleDOI
Angiotensin-converting-enzyme inhibition in stable coronary artery disease
Eugene Braunwald,Michael J. Domanski,Sarah E. Fowler,Nancy L. Geller,Bernard J. Gersh,Judith Hsia,Marc A. Pfeffer,Madeline Murguia Rice,Yves Rosenberg,Jean L. Rouleau,Peace Investigators +10 more
TL;DR: In patients with stable coronary heart disease and preserved left ventricular function who are receiving "current standard" therapy and in whom the rate of cardiovascular events is lower than in previous trials of ACE inhibitors, there is no evidence that the addition of an ACE inhibitor provides further benefit in terms of death from cardiovascular causes, myocardial infarction, or coronary revascularization.
Journal ArticleDOI
The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.
Trevor J. Orchard,Marinella Temprosa,Ronald B. Goldberg,Steven M. Haffner,Robert E. Ratner,Santica Marcovina,Sarah E. Fowler +6 more
TL;DR: In this paper, the authors used lifestyle intervention and metformin therapy to reduce the incidence of metabolic syndrome in the participants of the Diabetes Prevention Program. But, only half of the participants had the metabolic syndrome.